Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer Disease With Delusions”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Testing effectiveness (Phase 2)Looking for participantsNCT07459660
What this trial is testing

An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis

Who this might be right for
Psychosis Associated With Alzheimer's Disease
MapLight Therapeutics 210
Not applicableLooking for participantsNCT05847192
What this trial is testing

Tau Networks in Psychotic Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseAlzheimer Disease With DelusionsAlzheimer Disease With Psychosis
Northwell Health 91
Large-scale testing (Phase 3)Enrolling By InvitationNCT06194799
What this trial is testing

ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study

Who this might be right for
Alzheimer's Disease Psychosis
ACADIA Pharmaceuticals Inc. 752
Large-scale testing (Phase 3)Study completedNCT03325556
What this trial is testing

Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis

Who this might be right for
Dementia-related Psychosis
ACADIA Pharmaceuticals Inc. 392
Not applicableStudy completedNCT00015548
What this trial is testing

CATIE-Alzheimer's Disease Trial

Who this might be right for
Alzheimer's Disease
National Institute of Mental Health (NIMH) 450
Large-scale testing (Phase 3)Ended earlyNCT00287742
What this trial is testing

The Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementia
Janssen Pharmaceutical K.K. 33
Testing effectiveness (Phase 2)Looking for participantsNCT06887192
What this trial is testing

Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

Who this might be right for
Psychosis Associated With Alzheimer's Disease
MapLight Therapeutics 300
Testing effectiveness (Phase 2)Study completedNCT00073658
What this trial is testing

Treating Behavioral Disturbances in Individuals With Dementia

Who this might be right for
Dementia
University of Pittsburgh 137
Large-scale testing (Phase 3)Looking for participantsNCT06159673
What this trial is testing

ACP-204 in Adults With Alzheimer's Disease Psychosis

Who this might be right for
Alzheimer's Disease Psychosis
ACADIA Pharmaceuticals Inc. 1,074
Early research (Phase 1)UnknownNCT06388551
What this trial is testing

A Phase 1, SAD Study to Evaluate the Safety and Tolerability of LY03017

Who this might be right for
Hallucinations and Delusions Associated With Alzheimer's Disease PsychosisHallucinations and Delusions Associated With Parkinson Disease PsychosisNegative Symptoms of Schizophrenia
Luye Pharma Group Ltd. 60
Early research (Phase 1)Not Yet RecruitingNCT06980207
What this trial is testing

A Phase 1, MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY03017

Who this might be right for
Hallucinations and Delusions Associated With Alzheimer's Disease PsychosisHallucinations and Delusions Associated With Parkinson Disease PsychosisNegative Symptoms of Schizophrenia
Luye Pharma Group Ltd. 40